173 related articles for article (PubMed ID: 18991650)
1. Hypercoagulability in sickle cell disease and beta-thalassemia.
Singer ST; Ataga KI
Curr Mol Med; 2008 Nov; 8(7):639-45. PubMed ID: 18991650
[TBL] [Abstract][Full Text] [Related]
2. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
Ataga KI; Cappellini MD; Rachmilewitz EA
Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
[TBL] [Abstract][Full Text] [Related]
3. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
[TBL] [Abstract][Full Text] [Related]
4. Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.
Noubouossie D; Key NS; Ataga KI
Blood Rev; 2016 Jul; 30(4):245-56. PubMed ID: 26776344
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulability in sickle cell disease: new approaches to an old problem.
Ataga KI; Key NS
Hematology Am Soc Hematol Educ Program; 2007; ():91-6. PubMed ID: 18024615
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulability in sickle cell disease: a curious paradox.
Ataga KI; Orringer EP
Am J Med; 2003 Dec; 115(9):721-8. PubMed ID: 14693325
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
Hamali HA
Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
Stuart MJ; Setty BN
Pediatr Pathol Mol Med; 2001; 20(1):27-46. PubMed ID: 12673843
[TBL] [Abstract][Full Text] [Related]
10. Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy.
Levin C; Koren A
Isr Med Assoc J; 2011 May; 13(5):316-8. PubMed ID: 21845977
[No Abstract] [Full Text] [Related]
11. Hypercoagulability in β-thalassemia: a status quo.
Cappellini MD; Poggiali E; Taher AT; Musallam KM
Expert Rev Hematol; 2012 Oct; 5(5):505-11; quiz 512. PubMed ID: 23146054
[TBL] [Abstract][Full Text] [Related]
12. Aseptic necrosis of the femoral head due to sickle cell-thalassemia disease.
PAPASTAVROS CS
Del State Med J; 1957 Apr; 29(4):94-6. PubMed ID: 13414429
[No Abstract] [Full Text] [Related]
13. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
[TBL] [Abstract][Full Text] [Related]
14. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
Lv RY; Wen FQ; Yu J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
[TBL] [Abstract][Full Text] [Related]
15. "Don't Add Fuel to the Fire"- Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β0-Thalassemia: Case Report and Review of the Literature.
Rihsling A; Simeunovic H; Sanchez S; Henny C; Lejon Crottet S; Mansouri Teleghani B; Daskalakis M; Müller M; Raio L; Rovó A
Acta Haematol; 2024; 147(3):378-387. PubMed ID: 37839398
[TBL] [Abstract][Full Text] [Related]
16. Cerebral infarction in β-thalassemia intermedia: breaking the silence.
Musallam KM; Taher AT; Karimi M; Rachmilewitz EA
Thromb Res; 2012 Nov; 130(5):695-702. PubMed ID: 22857801
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study.
Hanna D; Beshir M; Khalifa N; Baz E; Elhewala A
Pediatr Hematol Oncol; 2021 Oct; 38(7):620-632. PubMed ID: 33724143
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Structural and Functional Changes in Children With β-Thalassemia and Sickle Cell Disease: Relationship to Sleep-disordered Breathing.
Elalfy MS; Youssef OI; Deghedy MMR; Abdel Naby MM
J Pediatr Hematol Oncol; 2018 Apr; 40(3):171-177. PubMed ID: 29494380
[TBL] [Abstract][Full Text] [Related]
20. How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.
Machogu EM; Machado RF
Blood; 2018 Oct; 132(17):1770-1780. PubMed ID: 30206115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
